Literature DB >> 30504339

Pediatric ITP: is it different from adult ITP?

Jenny M Despotovic1, Amanda B Grimes1.   

Abstract

Immune thrombocytopenia (ITP) has historically been thought to occur in 2 distinct forms: childhood ITP and adult ITP. This division is based largely on the presumption that childhood ITP is often benign and self-limited, whereas ITP in adults tends to be more chronic and difficult to treat. Although data exist to justify a different approach to the diagnosis and treatment in young children and the elderly, ITP in older children, adolescents, and younger adults is likely to share more similar pathology. This article will highlight the most recent data describing the natural history, diagnostic approach, management strategies, and disease-related outcomes in children and adults with ITP. These data reveal many unexpected similarities between the 2 groups, while confirming some of the more well-described differences. Discussion of these findings aims to highlight similarities and differences between ITP in children and adults, which will underscore important areas of future research and/or changes in management guidelines.
© 2018 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30504339      PMCID: PMC6246008          DOI: 10.1182/asheducation-2018.1.405

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  56 in total

1.  Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group.

Authors:  Thomas Kühne; Willi Berchtold; Lisa A Michaels; Runhui Wu; Hugo Donato; Bibiana Espina; Hannah Tamary; Francesco Rodeghiero; Meera Chitlur; Johannes Rischewski; Paul Imbach
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

2.  Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.

Authors:  Hiroyuki Tsuda; Takahiro Tsuji; Mayumi Tsuji; Hiroshi Yamasaki
Journal:  Ann Hematol       Date:  2017-08-14       Impact factor: 3.673

3.  The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia.

Authors:  Donald M Arnold; John R Vrbensky; Nadia Karim; James W Smith; Yang Liu; Nikola Ivetic; John G Kelton; Ishac Nazy
Journal:  Br J Haematol       Date:  2017-04-25       Impact factor: 6.998

4.  The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy.

Authors:  Thomas Sailer; Klaus Lechner; Simon Panzer; Paul Alexander Kyrle; Ingrid Pabinger
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

5.  Five hematologic tests and treatments to question.

Authors:  Lisa K Hicks; Harriet Bering; Kenneth R Carson; Adam E Haynes; Judith Kleinerman; Vishal Kukreti; Alice Ma; Brigitta U Mueller; Sarah H O'Brien; Julie A Panepinto; Marcelo C Pasquini; Anita Rajasekhar; Ravi Sarode; William A Wood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

6.  Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort.

Authors:  Adolfo Flores; Robert J Klaassen; George R Buchanan; Cindy E Neunert
Journal:  Pediatr Blood Cancer       Date:  2017-01-23       Impact factor: 3.167

Review 7.  The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.

Authors:  Deirdra R Terrell; Laura A Beebe; Sara K Vesely; Barbara R Neas; Jodi B Segal; James N George
Journal:  Am J Hematol       Date:  2010-03       Impact factor: 10.047

8.  Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.

Authors:  Francesco Rodeghiero; Roberto Stasi; Aristoteles Giagounidis; Jean-François Viallard; Bertrand Godeau; Ingrid Pabinger; Douglas Cines; Howard Liebman; Xuena Wang; Paul Woodard
Journal:  Eur J Haematol       Date:  2013-09-17       Impact factor: 2.997

9.  Temporal trends of splenectomy in pediatric hospitalizations with immune thrombocytopenia.

Authors:  Neel S Bhatt; Parth Bhatt; Keyur Donda; Fredrick Dapaah-Siakwan; Riddhi Chaudhari; Vijay Gandhi Linga; Bhumi Patel; Anusha Lekshminarayanan; Smita Bhaskaran; Samer Zaid-Kaylani; Sherif M Badawy
Journal:  Pediatr Blood Cancer       Date:  2018-04-10       Impact factor: 3.167

Review 10.  Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.

Authors:  Diane Nugent; Robert McMillan; Janet L Nichol; Sherrill J Slichter
Journal:  Br J Haematol       Date:  2009-05-14       Impact factor: 6.998

View more
  11 in total

1.  Response to rituximab in children and adults with immune thrombocytopenia (ITP).

Authors:  Emily M Harris; Kirsty Hillier; Hanny Al-Samkari; Laura Berbert; Rachael F Grace
Journal:  Res Pract Thromb Haemost       Date:  2021-08-24

2.  Immune thrombocytopenia associated with Hashimoto thyroiditis in a pediatric patient: A case report.

Authors:  Zhiqing Tian; Hu Gao; Dongqiong Xiao; Xihong Li
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 3.  Splenomegaly in Children and Adolescents.

Authors:  Meinolf Suttorp; Carl Friedrich Classen
Journal:  Front Pediatr       Date:  2021-07-09       Impact factor: 3.418

4.  Immune thrombocytopenic purpura caused by the over-the-counter weight supplement Root of Tejocote (Crataegus species).

Authors:  Hussam Alhasson; Eugene Muchnik
Journal:  Clin Case Rep       Date:  2020-03-20

5.  Evans syndrome in children below 13 years of age - A nationwide population-based cohort study.

Authors:  Nikolaj Mannering; Dennis Lund Hansen; Henrik Frederiksen
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

6.  Biological stratification of clinical disease courses in childhood immune thrombocytopenia.

Authors:  David E Schmidt; Katja M J Heitink-Pollé; Bart Mertens; Leendert Porcelijn; Rick Kapur; C Ellen van der Schoot; Gestur Vidarsson; Johanna G van der Bom; Marrie C A Bruin; Masja de Haas
Journal:  J Thromb Haemost       Date:  2021-03-18       Impact factor: 5.824

Review 7.  Assessment and Management of Immune Thrombocytopenia (ITP) in the Emergency Department: Current Perspectives.

Authors:  Tony Zitek; Luke Weber; Dominique Pinzon; Nicole Warren
Journal:  Open Access Emerg Med       Date:  2022-01-29

8.  Downregulation of ADAM17 in pediatric immune thrombocytopenia impairs proplatelet formation.

Authors:  Qi Wang; Jia Wei; Xi Jia; Xiao Feng; Zhenghua Ji; Xueqiang Ji; Xuejun Shao
Journal:  BMC Pediatr       Date:  2022-03-30       Impact factor: 2.125

9.  Investigation of the correlation between immune thrombocytopenia and T cell activity-regulated gene polymorphism using functional study.

Authors:  Ding-Ping Chen; Wei-Tzu Lin; Ying-Hao Wen; Wei-Ting Wang
Journal:  Sci Rep       Date:  2022-04-22       Impact factor: 4.996

10.  Outcomes of Eltrombopag Treatment and Development of Iron Deficiency in Children with Immune Thrombocytopenia in Turkey

Authors:  Ayça Koca Yozgat; Göksel Leblebisatan; Sinan Akbayram; Simge Çınar Özel; Zeynep Karakaş; Erol Erduran; Şebnem Yılmaz; Ülker Koçak; Şule Ünal; Gül Nihal Özdemir; Meryem Albayrak; Emine Zengin; Yeşim Oymak; Özcan Bör; Hasan Fatih Çakmaklı; Murat Söker; Dilek Gürlek Gökçebay; Hüseyin Tokgöz; Barış Malbora; Serap Karaman; Tiraje Celkan; İlgen Şaşmaz; Neşe Yaralı; Hale Ören; Ayşegül Ünüvar; Namık Yaşar Özbek
Journal:  Turk J Haematol       Date:  2020-03-17       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.